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Summary
 
Human cytomegalovirus downregulates the expression of human class I major histocompatibil-
ity complex (MHC) molecules by accelerating destruction of newly synthesized class I heavy
chains. The HCMV genome contains at least two genes, US11 and US2, each of which encode
a product sufficient for causing the dislocation of newly synthesized class I heavy chains from the
lumen of the endoplasmic reticulum to the cytosol. Based on a comparison of their abilities to
degrade the murine class I molecules H-2K
 
b
 
, K
 
d
 
, D
 
b
 
, D
 
d
 
, and L
 
d
 
, the US11 and US2 gene
products have non-identical specificities for class I molecules. Specifically, in human astrocy-
toma cells (U373-MG) transfected with the US11 gene, the K
 
b
 
, D
 
b
 
, D
 
d
 
, and L
 
d
 
 molecules ex-
pressed via recombinant vaccinia virus are rapidly degraded, whereas in US2-transfected cells,
only D
 
b
 
 and D
 
d
 
 are significantly destabilized. The diversity in HCMV-encoded functions that
interfere with class I–restricted presentation likely evolved in response to the polymorphism of
the MHC.
 
C
 
lass I MHC molecules present peptides derived from
proteins degraded in the cytosol to cytolytic T cells,
and as such are targets for viruses seeking to evade immune
recognition (1). The ability to downregulate the expression
of class I molecules in host cells has been documented for a
number of viruses, including adenovirus (2), herpes simplex
virus (3), and both mouse (4) and human cytomegalovirus
(5). In HCMV-infected cells, newly synthesized class I heavy
chains are rapidly degraded following their deposition in
the lumen of the ER (6–8). The HCMV gene product
US11 (“US11”), an ER-resident type I transmembrane gly-
coprotein, has been shown by transfection to be sufficient
to cause the selective degradation of endogenous class I
molecules (9). In the presence of US11, class I heavy chains
are dislocated from the lumen of the ER into the cytosol,
where they are deglycosylated by host 
 
N
 
-glycanase, and
then degraded by the proteasome (10). A second HCMV
gene product, US2, has also been observed to cause the
premature destruction of newly synthesized class I mole-
cules, apparently by the same pathway as described above
for US11 (9, 11). Since both US11 and US2 are expressed
at the same stage of infection, we sought to determine why
the virus might encode two separate proteins that appear to
function in the same manner.
One possibility is that US11 and US2 recognize overlap-
ping but nonidentical subsets of class I molecules. In the
initial comparison of the US11 and US2 transfectants, only
the degradation of endogenous human class I molecules was
studied, and no differences in allelic selectivity between
US11 and US2 were apparent (9–11). In human fibroblasts
infected with HCMV, all endogenous class I molecules ap-
peared to be destabilized (6–8). In mouse L cells (H-2k)
transfected with HLA-B27, the human, but not murine
class I molecules were degraded upon HCMV infection,
but the reason for this difference was not established (6). In
virus-infected cells, both US11 and US2 are presumably
expressed, and these experiments therefore cannot resolve
possible differences in substrate specificity between the two
viral proteins. To probe the specificities of US11 and US2,
we infected cell lines transfected with either US11 or US2
with a panel of recombinant vaccinia virus expressing dif-
ferent mouse class I heavy chains (H-2K
 
b
 
, K
 
d
 
, D
 
b
 
, D
 
d
 
, and
L
 
d
 
) to determine whether certain heavy chains would be
resistant to US11- or US2-mediated degradation. We ob-
serve that US11 and US2 differ in their abilities to degrade
murine class I heavy chains, and thus are not functionally
redundant. Specifically, we find that US11 degrades K
 
b
 
,
D
 
b
 
, D
 
d
 
, and L
 
d
 
 efficiently, whereas US2 is most effective in
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degrading D
 
b
 
 and D
 
d
 
. We suggest that MHC polymor-
phism drives diversification of viral evasion strategies.
 
Materials and Methods
 
Cells and Vaccinia Virus Infections.
 
U373-MG astrocytoma cells
and the US11 and US2 transfectants prepared from this cell line
have been described (9). Cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% (vol/vol) FCS,
penicillin (1:1,000 dilution U/ml), streptomycin (100 
 
m
 
g/ml),
and puromycin (Sigma Chem. Co., St. Louis, MO) at a final con-
centration of 0.375 
 
m
 
g/ml. Recombinant vaccinia virus express-
ing H-2K
 
b
 
 (lacking the cytoplasmic tail), K
 
d
 
, D
 
b
 
, D
 
d
 
, and L
 
d
 
 were
obtained from Dr. J. Yewdell. Between 1 and 5 
 
3
 
 10
 
6
 
 cells per
sample were detached by treatment with trypsin, resuspended in
PBS supplemented with 1% FCS, penicillin, and streptomycin,
and then infected for 45 min with recombinant vaccinia virus at a
multiplicity of infection of 10, after which 10 ml of media was
added. 5 h later, cells were starved in methionine/cysteine-free
medium for 45 min with or without the proteasome inhibitor
Cbz-LLL (10 
 
m
 
m final) (10) before labeling with 250 
 
m
 
Ci/ml
[
 
35
 
S]methionine/cysteine (80:20). Labeling was terminated by ad-
dition of 1 mM cold methionine/cysteine to the labeling mix.
Aliquots of cells were spun down at each chase point, and the cell
pellets frozen before immunoprecipitation of class heavy chains.
Figure 1. Fate of murine class I MHC heavy chains in US111 or US21
cells. Control (nontransfected), US111, or US21 cells were infected with
vaccinia virus expressing H-2Kb (lacking the cytoplasmic tail; A), Kd (B),
Db (C), Dd (D), or Ld (E), labeled with [35S]methionine for 10 min and
chased as indicated. Immunoprecipitated murine class I molecules were
resolved on a 12.5% SDS–polyacrylamide gel and visualized by fluorogra-
phy. The position of the breakdown intermediate is indicated with an as-
terisk. 
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Antibodies and Immunoprecipitations.
 
For immunoprecipitation
of mouse class I heavy chains, a rabbit polyclonal antiserum (RafHC)
which recognizes non-assembled or unfolded heavy chains was
used (12). Cell pellets were each lysed in 1 ml ice-cold lysis mix
(0.5% NP-40, 50 mM Tris/HCl, pH 7.4, 5 mM MgCl, 1 mM
PMSF, and 10 mM iodoacetamide), and the postnuclear superna-
tant precleared twice with 10% fixed 
 
Staphylococcus aureus
 
 before
specific immunoprecipitation of murine class I heavy chains with
RafHC. To enhance the visualization of degradation intermedi-
ates, the RafHC immunoprecipitates were boiled in denaturation
buffer (2% SDS, 50 mM Tris/HCl, pH 7.8, 1 mM EDTA, 5 mM
DTT), and the murine class I material re-immunoprecipitated
with RafHC before gel analysis. The 
 
N
 
-glycanase digestions in
Fig. 2 were performed according to the manufacturer instructions
(Boehringer Mannheim, Germany). SDS-PAGE and one dimen-
sional isoelectric focusing were performed as described (13).
 
Results
 
The Murine Class I MHC Molecule H-2K
 
b
 
 Is Degraded by
US11 but not by US2.
 
To probe the specificity of the
HCMV gene products US11 and US2 for class I MHC
molecules, we infected parental U373-MG cells, and trans-
fectants expressing either US11 or US2, with a panel of re-
combinant vaccinia virus encoding different mouse class I
heavy chains, and then performed a pulse chase experiment
(10-min labeling, 0-min and 20-min chase points) in the
presence of the proteasome inhibitor Cbz-LLL (Fig. 1). At
each chase point, aliquots of cells were pelleted and frozen
at 
 
2
 
80
 
8
 
C before lysis and immunoprecipitation with a rabbit
anti-free heavy chain antiserum (RafHC). Immunoprecipi-
tates were denatured by boiling in 2% SDS, and re-immu-
noprecipitated before analysis by SDS-PAGE. In the case
of H-2K
 
b
 
 (lacking cytoplasmic tail) vaccinia virus-infected
cells (Fig. 1 
 
A
 
), class I heavy chains synthesized in the 10-
min pulse are stable throughout the 20-min chase in con-
trol cells and in US2
 
1
 
 cells. However, in US11
 
1
 
 cells, the
fully intact K
 
b
 
 heavy chains observed immediately upon
completion of labeling (Fig. 1 
 
A
 
, 0-min timepoint) are rap-
idly converted into a faster migrating species. If the pulse
chase is performed in the absence of Cbz-LLL, then the K
 
b
 
heavy chains in US11
 
1
 
 cells are fully degraded by 20 min,
and no intermediates accumulate (data not shown).
US11 and US2 were equally capable of degrading the
murine class I MHC heavy chains H-2D
 
b
 
 (Fig. 1 
 
C
 
), and
D
 
d
 
 (Fig. 1 
 
D
 
). However, when challenged with the H-2L
 
d
 
molecule (Fig. 1 
 
E
 
), US11 was more efficient than US2 at
causing the breakdown of the heavy chains, as evidenced
by the nearly complete conversion in US11
 
1
 
 cells of full-
length L
 
d
 
 heavy chains into the breakdown intermediate
over the 20-min chase. In the case of H-2K
 
d
 
 (Fig. 1 
 
B
 
), the
heavy chains decay more rapidly in the presence of either
US11 or US2 than in control cells, but little degradation
intermediate accumulates in either transfectant, despite the
presence of the inhibitor Cbz-LLL. This is most likely due
to the comparatively lower rate of degradation for K
 
d
 
, cou-
pled with the earlier observation that Cbz-LLL retards, but
does not block, the subsequent degradation of the heavy
chain intermediate (10). Thus, while US2 can apparently
destabilize the K
 
d
 
 and L
 
d
 
 heavy chains to some extent, it
does not cause their destruction at a rate sufficient for the
intermediate to accumulate.
 
The K
 
b
 
 Degradation Intermediate Observed Is a Deglycosylated
Heavy Chain.
 
In the case of human class I MHC mole-
cules, the US11-induced degradation intermediate that ac-
cumulates in the presence of Cbz-LLL is a deglycosylated
heavy chain (10). To demonstrate that the K
 
b
 
 degradation
intermediate observed in Fig. 1 is a deglycosylated heavy
chain, we performed a pulse chase experiment (10-min la-
bel, 0-min and 20-min chase points) on K
 
b
 
 vaccinia virus
infected US11 cells, and immunoprecipitated with RafHC
the K
 
b
 
 heavy chains from lysates of cells removed at each
chase point. Each immunoprecipitate was split in two, and
either kept on ice (
 
2
 
) or treated with recombinant 
 
N
 
-gly-
canase (
 
1
 
) before re-immunoprecipitation with RafHC.
The samples were then split again and analyzed by SDS-
PAGE (Fig. 2 
 
A
 
) or 1D-IEF (Fig. 2 
 
B
 
). As seen in Fig. 2 
 
A
 
,
all of the K
 
b
 
 molecules at the beginning of the chase are
fully susceptible to 
 
N
 
-glycanase treatment (Fig. 2 
 
A
 
, 0-min
timepoint), and no intermediate has yet accumulated. After
20 min, most of the heavy chains have been converted into
the US11-induced fragment, which migrates at the same
position as 
 
N
 
-glycanase treated material (Fig. 2 
 
A
 
, 20-min
timepoint). In hydrolyzing the 
 
N
 
-glycosidic bond of the K
 
b
Figure 2. The Kb degradation intermediate is a deglycosylated heavy
chain. US111 cells were infected with vaccinia virus expressing H-2Kb
(lacking cytoplasmic tail), labeled for 10 min with [35S]methionine, and
chased as indicated. Immunoprecipitated Kb heavy chains from each chase
point were either kept on ice (2) or treated with recombinant N-glyca-
nase (1) before resolution by SDS-PAGE (A) or 1D-IEF (B).366 Specificity of US11 and US2 for Murine Class I MHC
heavy chain’s glycan, N-glycanase converts the Asn side-
chain to an Asp, and thus imparts an additional negative
charge upon the molecule. Isoelectric focusing of the sam-
ples in Fig. 2 Areveals that the fully intact Kb heavy chains
present at the beginning of the chase have the same pI after
N-glycanase treatment as the degradation intermediate ob-
served after 20 min of chase (Fig. 2 B). We conclude that
the mechanism of US11-mediated class I heavy chain deg-
radation is similar for mouse and human molecules, and
that in both cases, a deglycosylated heavy chain intermedi-
ate can be visualized when the proteasome inhibitor Cbz-
LLL is present during the chase.
HCMV downregulates the expression of class I MHC
molecules by dislocating newly synthesized class I heavy
chains from the lumen of the ER back into the cytosol,
where they are rapidly degraded (10). The virus encodes
two proteins, US11 and US2, that are each sufficient for
causing the premature destruction of class I heavy chains
(9, 11). We show here that US11 and US2 have nonidenti-
cal specificities for a panel of murine class I heavy chains.
Over the 20-min chase period examined, US11 degraded
H-2Kb, Db, Dd, and Ld with similar kinetics, while US2
only degraded Db and Dd efficiently. One possible explana-
tion for the observed differences in class I heavy chain deg-
radation for US11 and US2 positive cells is that each may
interact with different regions of the class I heavy chain in
the process of dislocating the latter into the cytosol. Due to
the sequence variability between different class I alleles, this
dual recognition strategy would allow the virus to down-
regulate the expression of a broader range of class I mole-
cules than might be possible with either US11 or US2
alone.
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